Related Experiment Videos
Alkaline phosphatase and calcification, correlated or not?
Metabolic Bone Disease & Related Research
|January 1, 1981
Summary
Alkaline phosphatase inhibitors did not clarify the enzyme's role in calcification. The study found these inhibitors also block other cellular processes, making them unsuitable for research.
Area of Science:
- Biochemistry
- Developmental Biology
- Skeletal Biology
Background:
- Alkaline phosphatase is an enzyme implicated in various biological processes, including bone mineralization.
- Understanding the precise role of alkaline phosphatase in calcification is crucial for developmental and skeletal biology.
Purpose of the Study:
- To investigate the relationship between alkaline phosphatase activity and in vitro calcification using specific inhibitors.
- To determine if alkaline phosphatase is a critical factor in the calcification process.
Main Methods:
- Dissection and in vitro culture of embryonic mouse metatarsal bones.
- Treatment with alkaline phosphatase inhibitors (levamisole, L-bromotetramisole) and a non-inhibitory isomer (D-bromotetramisole).
- Biochemical and histochemical assays for enzyme activity, calcification, and cellular incorporation of 3H-thymidine and 35S-sulphate.
Main Results:
- Levamisole and L-bromotetramisole inhibited both alkaline phosphatase activity and in vitro calcification.
- These inhibitors also reduced the incorporation of 3H-thymidine and 35S-sulphate.
- D-bromotetramisole, lacking alkaline phosphatase inhibitory effects, also impaired calcification and cellular incorporation.
Conclusions:
- The tested inhibitors are not suitable for elucidating the role of alkaline phosphatase in calcification due to off-target effects.
- While alkaline phosphatase may contribute to calcification, it is likely not the sole critical factor.